3,4-dihydroxyphenylacetate 2,3-dioxygenase

BE0002510ProteinArthrobacter globiformismndD

3,4-dihydroxyphenylacetate 2,3-dioxygenase (Arthrobacter globiformis) is a protein target in DrugBank. It is acted on by 1 drug in DrugBank.

Gene name
mndD
UniProtKB entry
Q44048TrEMBL
Residues / weight
343 residues · 38,861 Da

Resolves to

Protein
UniProtQ44048UniProt nameQ44048_ARTGO
Structure
PDB1F1RPDB1F1UPDB1F1V
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
2GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on 3,4-dihydroxyphenylacetate 2,3-dioxygenase, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In